-The Hindu The battle against COVID-19 should also be used as an opportunity to meet India’s ‘One Health’ targets The father of modern pathology, Rudolf Virchow, emphasised in 1856 that there are essentially no dividing lines between animal and human medicine. This concept is ever more salient as the world continues to grapple with the COVID-19 pandemic. Discussions that took place around World Veterinary Day, on April 24, 2021, focused on acknowledging...

-Down to Earth The Earth needs to resurrect and heal. It is the right time to define collective growth and prosperity, not in terms of rising income but rising ecological wellbeing Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome and Ebola have shaken the global economy and society in the last two decades. The novel coronavirus disease (COVID-19) disease is following suit. The nature has hit a reset button. Economies are in a...

-Economic and Political Weekly The Ministry of Health and Family Welfare has made public the National Health Policy 2015 Draft for discussion. The draft is more exhaustive and better organised in its coverage compared to the National Health Policy of 2002. It touches upon contemporary issues of concern, including the rapid emergence of chronic non-communicable diseases. From the latest available evidence, issues crucial to tackling chronic illness in India are discussed. Subrata...

-The Indian Express Ganga Ram docs link ‘benign’ parasite with platelet drop, liver problems. A malaria parasite responsible for the milder form of the disease — Plasmodium vivax — has been linked with severe complications in patients. A new study by Sir Ganga Ram Hospital doctors on 165 patients, published in the journal Tropical Doctor, says the parasite may be deadlier than thought. Of 121 patients diagnosed with vivax malaria, three died of...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...